HIT Consultant

MARCH 24, 2022

These inconsistencies and inaccuracies tend to compound in medical device and medical technology organizations where product portfolios are continually evolving, pricing fluctuates and quotes have to be configured to meet the specifications of each customer. But there are also some precautions to take with CPQ software.

Life Sciences 98

Life Sciences Medical Technology Pharmaceuticals Integration 98

Health Populi

OCTOBER 6, 2021

That a pharmaceutical company executive is speaking on the main stage at CES speaks to the category’s mainstreaming beyond elite athletes and smartwatches that track activity.

Pharmaceuticals 147

Pharmaceuticals Doctors Health Technology Medical Technology 147

Healthcare ECONOMIST

DECEMBER 13, 2021

The key findings from the article are: HTA practices are designed to be used for medical technologies and pharmaceuticals that treat commonly-occurring diseases, and are not fit to determine the value of orphan drugs for rare disease, which face unique challenges. As of 2020, all orphan drugs in the U.S.

Medical Technology 75

Medical Technology Pharmaceuticals Accountability 75

HIT Consultant

MARCH 18, 2024

These microservices, with 25 newly launched offerings, are poised to expedite healthcare workflows in drug discovery, medical imaging, and genomics analysis. Within the NVIDIA AI Enterprise 5.0 software platform, NIM provides elevated capabilities in generative biology, chemistry, and molecular prediction.

Healthcare 96

Healthcare Pharmaceuticals Healthcare Innovation Medical Technology 96

Home Health Care

JUNE 14, 2024

GE HealthCare is a global medical technology, pharmaceutical diagnostics and digital solutions provider. “His experience leading HR teams spans a variety of global companies and industries, including healthcare, and it will help us further serve our people, patients, and customers.”

Healthcare 111

Healthcare Physical Therapy Pharmaceuticals Integration 111

HIT Consultant

SEPTEMBER 1, 2021

With this in mind, it is critical that both payers and providers in VBC arrangements consider how their data flows through the entire system so that key partners, such as life sciences and pharmaceutical companies – have real-world insights (RWI) about the impact their medication is having on outcomes.

Life Sciences 97

Life Sciences Pharmaceuticals Medical Technology Healthcare 97

HIT Consultant

OCTOBER 16, 2024

– The platform—which includes Honeywell’s TrackWise Quality , Salesforce Life Sciences Cloud , Agentforce, and other solutions—will help pharmaceutical and medical technology companies deliver critical medications and healthcare devices to patients more quickly, safely, and affordably.

Life Sciences 52

Life Sciences Pharmaceuticals Integration Medical Technology 52

Bill Of Health

SEPTEMBER 22, 2022

After graduating from law school, she has trained at Hogan Lovells in their Milan office, specializing in pharmaceutical patent litigation. Her research currently focuses on the interplay between intellectual property, transfer of technology, and financing to further access to medical technologies. Louis (USA).

Biotechnology 52

Biotechnology Pharmaceuticals Medical Technology Regulations 52

HIT Consultant

APRIL 8, 2024

About Model N Model N is a leader in revenue optimization and compliance solutions, empowering companies in the pharmaceutical, medical technology, and high-tech sectors. Upon completion, Model N will become a privately held company and its shares will be delisted from any public stock exchange.

Life Sciences 52

Life Sciences Pharmaceuticals Medical Technology Integration 52

HIT Consultant

JULY 24, 2024

What You Should Know: – SoundHealth , a medical technology company focused on harnessing AI for better health outcomes, has launched SONU , the world’s first FDA-cleared AI-powered wearable for treating moderate to severe nasal congestion. SONU Band: Breakthrough drug-free treatment for nasal congestion due to allergies.

Pharmaceuticals 52

Pharmaceuticals Medical Technology Doctors 52

Health Populi

MARCH 10, 2025

Each year, ECRI (the ECRI Institute) publishes an annual report on the Top 10 Patient Safety Concerns for the year. The 2025 list was published today. My read of it is that most of these risks have to do with what I’ve been referring to as the Human OS, the Human Operating System, in my talks and teachings.

Patient Safety 78

Patient Safety Doctors Healthcare Hospitals 78

Healthcare ECONOMIST

MARCH 5, 2025

At a high level, the approach combines expected utility theory with value of information (VOI) metrics to inform value-based prices (VBP) of new medical technologies. The paper by Jiao et al. 2025) provides the theoretical foundations for why this three-part pricing approach is so sensible.

Medical Technology 40

Medical Technology Accountability Medicaid Pharmaceuticals 40

Health Populi

APRIL 14, 2025

As Weight Watchers prepares to initiate bankruptcy proceedings, I file the news event under “thinking the unthinkable.” ” “Thinking about the unthinkable” is what Herman Kahn, a father of scenario planning, asked us to do when he pioneered the process.

Healthcare 71

Healthcare Hospitals Medicaid Home Care 71

HIT Consultant

JUNE 18, 2024

What You Should Know: – Salesforce announced the general availability of Life Sciences Cloud , a platform for pharmaceutical ( pharma ) and medical technology ( medtech ) organizations to help personalize patient and healthcare professional (HCP) engagement and streamline clinical operations with data, automation, and trusted AI.

Life Sciences 59

Life Sciences Pharmaceuticals Medical Technology Integration 59

Bill Of Health

SEPTEMBER 16, 2024

She is interested in mass torts, drug product liability, pharmaceutical antitrust, and the administrative law that affects health-related regulations promulgated by agencies. 2026) research interests include innovative medical technologies and chronic disease policy. Rebekah Ninan’s (J.D. Rupa Palanki’s (J.D.

Biotechnology 40

Biotechnology Pharmaceuticals Health Science Medical Technology 40

Bill Of Health

MARCH 23, 2023

Is research in the interest of the public domain an activity exclusively developed by academic or healthcare entities, or can it be carried out by industry (pharmaceutical, biotechnology, technology companies, medical technology industries, and insurance providers)? If so, how?

Health Data 52

Health Data Regulations Biotechnology Pharmaceuticals 52

Health Populi

JULY 2, 2018

Most Americans say that pharmaceutical manufacturers, banks, advertisers, energy firms, and tech companies have too much power and influence in today’s American economy, according to Public Attitudes Toward Technology Companies , a research report from the Pew Research Center. economy.

Healthcare 48

Healthcare Regulations Pharmaceuticals Health Data 48

Health Populi

DECEMBER 2, 2019

The idea of health care consumerism isn’t just an American discussion, Deloitte points out in its 2019 global survey of healthcare consumers report, A consumer-centered future of health.

Doctors 100

Doctors Hospitals Prevention Health Data 100

Bill Of Health

SEPTEMBER 20, 2022

Dose shortages elevated the role of pharmaceutical executives. Pharmaceutical corporations hoarded technology that could have helped alleviate scarcity. At the end of 2021, Thomas Cueni, the head of an international pharmaceutical trade association, acknowledged that everyone was “ashamed and embarrassed” by the inequity. “We

Pharmaceuticals 98

Pharmaceuticals Medical Technology Regulations Health Technology 98

Healthcare ECONOMIST

MAY 18, 2023

Actual testimony ) Dr. Darius Lakdawalla Professor of Pharmaceutical Economics and Public Policy, USC Leonard D. He proposed a balanced policy approach that includes generous prescription drug coverage, drug prices aligned with the value delivered to patients, and robust competition within the pharmaceutical supply chain.

Pharmaceuticals 81

Pharmaceuticals Medicare Medical Technology Primary Care 81

Health Populi

APRIL 1, 2022

To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments. To scale what works, based on evidence and proven interventions — which depends on our reducing biases in our assumptions, models and strategies.

Life Sciences 127

Life Sciences Pharmaceuticals Prevention Medical Technology 127

Healthcare ECONOMIST

MAY 30, 2023

Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medical technologies, particularly in Eastern Europe and developing countries. The abstract is below.

Life Sciences 81

Life Sciences Pharmaceuticals Medical Technology Health Technology 81

Health Populi

DECEMBER 19, 2022

The company is offering a hearing device integrating deep neural network technology that offers “BrainHearing through the ear” in a customized hearing aid. Last year, Abbott made a big splash with the company’s Board Chairman/CEO delivering a keynote addressing connected care.

Life Sciences 62

Life Sciences Pharmaceuticals Health Technology Health Data 62

Bill Of Health

NOVEMBER 7, 2023

From national disparities across populations, to global inequalities in access, to scarce medical technologies, from ventilators to vaccines, inequalities have been an overriding feature of this pandemic. Deep inequities and discrimination were manifested across the board.

Accountability 115

Accountability Regulations Medical Technology Pharmaceuticals 115

Patient Safety Movement

DECEMBER 1, 2022

A recent commentary in the Journal of Pharmaceutical Policy and Practice reveals that branded drug samples handed out by the pharmaceutical industry actually increase drug costs for everyone and can compromise patient safety.

Patient Safety 52

Patient Safety Prevention Hospitals Pharmaceuticals 52

Health Populi

NOVEMBER 5, 2019

health care economics, patients are now payors as health consumers with more financial skin in paying medical bills. As consumers, people have great expectations from the organizations on the supply side of health care — providers (hospitals and doctors), health insurance plans, pharma and medical device companies.

Hospitals 66

Hospitals Doctors Healthcare Medical Technology 66

HIT Consultant

NOVEMBER 23, 2022

The disclosure of the genetic code went a long way to pinpointing the origins and the spread of the disease, and also to pharmaceutical targets for drug development. About Ivor Campbell Ivor Campbell is the CEO of Snedden Campbell , a UK-based recruitment agency for the global medical technology industry.

Medical Technology 52

Medical Technology Hospitals Prevention Nursing 52

Healthcare ECONOMIST

DECEMBER 28, 2022

 In the context of this fast-moving political debate, FTI Consulting supported INTERPAT, a non-profit biopharmaceutical consortium, and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) in developing a White Paper and peer-reviewed article on the role of IP in the biopharmaceutical sector.

Life Sciences 85

Life Sciences Pharmaceuticals Medical Technology Regulations 85

HIT Consultant

AUGUST 18, 2021

The acceleration of digital advancements and collaborative practices amongst the pharmaceutical industry during COVID-19 have enabled a historic rollout of vaccines. He has spent his career supporting healthcare companies through technological transformation, starting in the UK as a CRA for BRI International.

Regulations 52

Regulations Pharmaceuticals Integration Medical Technology 52

Health Populi

AUGUST 6, 2021

The infection rate is once again trending up, presumably due to a combination of factors including a dramatic reduction in demand for new vaccinations, the rapid spread of the more infectious Delta variant in the U.S., as well as the reduction in mitigation measures.” ” .

Tertiary Care 162

Tertiary Care Primary Care Prevention Hospitals 162

HIT Consultant

DECEMBER 12, 2024

Key investors Deerfield Management, Foresite Capital and Medical Excellence Capital remain committed to supporting the next phase of the companys growth strategy. Dr. Vaz Bio/Background Dr. Vaz an actively licensed physician with training and experience from prestigious institutions like Harvard Medical School and the University of Miami.

Life Sciences 52

Life Sciences Pharmaceuticals Medical Technology 52

Patient Safety Movement

JANUARY 31, 2024

Often regarded as the “Father of Pharmacy,” Porter founded the American Pharmaceutical Association in 1852. The Foundation’s annual World Patient Safety, Science & Technology Summit brings together all stakeholders, including patients, healthcare providers, medical technology companies, government employers, and private payers.

Patient Safety 52

Patient Safety Prevention Hospitals Pharmaceuticals 52

Bill Of Health

AUGUST 12, 2021

Activists anticipated the rise of vaccine, therapeutic, and testing nationalism — with rich countries securing preferential access to COVID-19 medical technologies and preventing export to other countries even before they had been approved — and the press soon followed.

Medical Technology 124

Medical Technology Prevention Health Technology Biotechnology 124

Health Populi

APRIL 7, 2025

Americans’ financial health was already stressing consumers out leading up to Liberation Day, April 2nd , when President Trump announced tariffs on dozens of countries with whom the U.S. buys and sells goods.

Doctors 71

Doctors Hospitals Accountability Medicaid 71

Bill Of Health

DECEMBER 3, 2024

PBMs: The Health Care Middlemen PBMs act as intermediaries among pharmaceutical companies, drug wholesalers, pharmacies, and health insurers. By addressing the anti-competitive behaviors of these “medication gatekeepers,” the federal government can ensure that lifesaving medications remain within reach for all Americans.

Regulations 75

Regulations Pharmaceuticals Accountability Medical Technology 75